The role of obesity and adipose tissue dysfunction in osteoarthritis pain.

Wallace, I. J. et al. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc. Natl Acad. Sci. USA 114, 9332–9336 (2017).

pubmed: 28808025 pmcid: 5584421 doi: 10.1073/pnas.1703856114

Hunter, D. J. & Bierma-Zeinstra, S. Osteoarthritis. Lancet 393, 1745–1759 (2019).

pubmed: 31034380 doi: 10.1016/S0140-6736(19)30417-9

Safiri, S. et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann. Rheum. Dis. 79, 819–828 (2020).

pubmed: 32398285 doi: 10.1136/annrheumdis-2019-216515

Blüher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288–298 (2019).

pubmed: 30814686 doi: 10.1038/s41574-019-0176-8

González-Muniesa, P. et al. Obesity. Nat. Rev. Dis. Prim. 3, 17034 (2017).

pubmed: 28617414 doi: 10.1038/nrdp.2017.34

The GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377, 13–27 (2017).

doi: 10.1056/NEJMoa1614362

Berenbaum, F., Wallace, I. J., Lieberman, D. E. & Felson, D. T. Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 14, 674–681 (2018).

pubmed: 30209413 doi: 10.1038/s41584-018-0073-x

Zheng, H. & Chen, C. Body mass index and risk of knee osteoarthritis: systematic review and meta-analysis of prospective studies. BMJ Open 5, e007568 (2015).

pubmed: 26656979 pmcid: 4679914 doi: 10.1136/bmjopen-2014-007568

Reyes, C. et al. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study: overweight/obesity and the risk of developing OA. Arthritis Rheumatol. 68, 1869–1875 (2016).

pubmed: 27059260 pmcid: 4966641 doi: 10.1002/art.39707

Yusuf, E. et al. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann. Rheum. Dis. 69, 761–765 (2010).

pubmed: 19487215 doi: 10.1136/ard.2008.106930

Visser, A. et al. Adiposity and hand osteoarthritis: the Netherlands Epidemiology of Obesity study. Arthritis Res. Ther. 16, R19 (2014).

pubmed: 24447395 pmcid: 3978723 doi: 10.1186/ar4447

Collins, K. H. et al. Adipose tissue is a critical regulator of osteoarthritis. Proc. Natl Acad. Sci. USA 118, e2021096118 (2021).

pubmed: 33443201 doi: 10.1073/pnas.2021096118

Kahn, C. R., Wang, G. & Lee, K. Y. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J. Clin. Invest. 129, 3990–4000 (2019).

pubmed: 31573548 pmcid: 6763230 doi: 10.1172/JCI129187

Kawai, T., Autieri, M. V. & Scalia, R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am. J. Physiol. Cell Physiol. 320, C375–C391 (2021).

pubmed: 33356944 doi: 10.1152/ajpcell.00379.2020

Malfait, A.-M. & Schnitzer, T. J. Towards a mechanism-based approach to pain management in osteoarthritis. Nat. Rev. Rheumatol. 9, 654–664 (2013).

pubmed: 24045707 pmcid: 4151882 doi: 10.1038/nrrheum.2013.138

Gossec, L. et al. The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthr. Cartil. 19, 147–154 (2011).

doi: 10.1016/j.joca.2010.10.025

Neogi, T. The epidemiology and impact of pain in osteoarthritis. Osteoarthr. Cartil. 21, 1145–1153 (2013).

doi: 10.1016/j.joca.2013.03.018

Losina, E., Song, S., Bensen, G. P. & Katz, J. N. Opioid use among medicare beneficiaries with knee osteoarthritis: prevalence and correlates of chronic use. Arthritis Care Res. 75, 876–884 (2023).

doi: 10.1002/acr.24844

Eitner, A., Hofmann, G. O. & Schaible, H.-G. Mechanisms of osteoarthritic pain. studies in humans and experimental models. Front. Mol. Neurosci. 10, 349 (2017).

pubmed: 29163027 pmcid: 5675866 doi: 10.3389/fnmol.2017.00349

Jinks, C., Jordan, K. P., Blagojevic, M. & Croft, P. Predictors of onset and progression of knee pain in adults living in the community. A prospective study. Rheumatology 47, 368–374 (2007).

doi: 10.1093/rheumatology/kem374

Chin, S.-H., Huang, W.-L., Akter, S. & Binks, M. Obesity and pain: a systematic review. Int. J. Obes. 44, 969–979 (2020).

doi: 10.1038/s41366-019-0505-y

Wluka, A. E., Lombard, C. B. & Cicuttini, F. M. Tackling obesity in knee osteoarthritis. Nat. Rev. Rheumatol. 9, 225–235 (2013).

pubmed: 23247649 doi: 10.1038/nrrheum.2012.224

Murphy, L. et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 59, 1207–1213 (2008).

pubmed: 18759314 pmcid: 4516049 doi: 10.1002/art.24021

Raud, B. et al. Level of obesity is directly associated with the clinical and functional consequences of knee osteoarthritis. Sci. Rep. 10, 3601 (2020).

pubmed: 32107449 pmcid: 7046749 doi: 10.1038/s41598-020-60587-1

Emery, C. F., Finkel, D. & Dahl Aslan, A. K. Bidirectional associations between body mass and bodily pain among middle-aged and older adults. Pain 163, 2061–2067 (2022).

pubmed: 35121695 doi: 10.1097/j.pain.0000000000002603

Collins, A. T. et al. Obesity alters the in vivo mechanical response and biochemical properties of cartilage as measured by MRI. Arthritis Res. Ther. 20, 232 (2018).

pubmed: 30333058 pmcid: 6235204 doi: 10.1186/s13075-018-1727-4

Robbins, S. M. et al. Association of pain with frequency and magnitude of knee loading in knee osteoarthritis. Arthritis Care Res. 63, 991–997 (2011).

doi: 10.1002/acr.20476

Chen, L. et al. Pathogenesis and clinical management of obesity-related knee osteoarthritis: impact of mechanical loading. J. Orthop. Transl. 24, 66–75 (2020).

Beckwée, D. et al. The influence of joint loading on bone marrow lesions in the knee: a systematic review with meta-analysis. Am. J. Sports Med. 43, 3093–3107 (2015).

pubmed: 25634907 doi: 10.1177/0363546514565092

Aso, K., Shahtaheri, S. M., McWilliams, D. F. & Walsh, D. A. Association of subchondral bone marrow lesion localization with weight-bearing pain in people with knee osteoarthritis: data from the Osteoarthritis Initiative. Arthritis Res. Ther. 23, 35 (2021).

pubmed: 33468243 pmcid: 7816469 doi: 10.1186/s13075-021-02422-0

Felson, D. T., Goggins, J., Niu, J., Zhang, Y. & Hunter, D. J. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum. 50, 3904–3909 (2004).

pubmed: 15593215 doi: 10.1002/art.20726

Lo, G. H., Harvey, W. F. & McAlindon, T. E. Associations of varus thrust and alignment with pain in knee osteoarthritis. Arthritis Rheum. 64, 2252–2259 (2012).

pubmed: 22307813 pmcid: 3368024 doi: 10.1002/art.34422

Mohamed, N. S. et al. The rise of obesity among total knee arthroplasty patients. J. Knee Surg. 35, 001–006 (2022).

doi: 10.1055/s-0040-1710566

Weiss, E. Knee osteoarthritis, body mass index and pain: data from the Osteoarthritis Initiative. Rheumatology 53, 2095–2099 (2014).

pubmed: 24939675 pmcid: 4202024 doi: 10.1093/rheumatology/keu244

Cimmino, M. A. et al. Body mass and osteoarthritic pain: results from a study in general practice. Clin. Exp. Rheumatol. 31, 843–849 (2013).

pubmed: 24144227

Gløersen, M. et al. Associations of body mass index with pain and the mediating role of inflammatory biomarkers in people with hand osteoarthritis. Arthritis Rheumatol. 74, 810–817 (2022).

pubmed: 35137553 pmcid: 9050744 doi: 10.1002/art.42056

Magnusson, K. et al. Body mass index and progressive hand osteoarthritis: data from the Oslo hand osteoarthritis cohort. Scand. J. Rheumatol. 44, 331–336 (2015).

pubmed: 25742965 doi: 10.3109/03009742.2014.994560

Glass, N. et al. Examining sex differences in knee pain: the Multicenter Osteoarthritis Study. Osteoarthr. Cartil. 22, 1100–1106 (2014).

doi: 10.1016/j.joca.2014.06.030

Vaughn, I. A., Terry, E. L., Bartley, E. J., Schaefer, N. & Fillingim, R. B. Racial-ethnic differences in osteoarthritis pain and disability: a meta-analysis. J. Pain. 20, 629–644 (2019).

pubmed: 30543951 doi: 10.1016/j.jpain.2018.11.012

Zheng, S. et al. Depression in patients with knee osteoarthritis: risk factors and associations with joint symptoms. BMC Musculoskelet. Disord. 22, 40 (2021).

pubmed: 33413273 pmcid: 7791830 doi: 10.1186/s12891-020-03875-1

van Tunen, J. A. C. et al. Association of osteoarthritis risk factors with knee and hip pain in a population-based sample of 29–59 year olds in Denmark: a cross-sectional analysis. BMC Musculoskelet. Disord. 19, 300 (2018).

pubmed: 30126395 pmcid: 6102878 doi: 10.1186/s12891-018-2183-7

Glass, N. A. et al. The relationship between quadriceps muscle weakness and worsening of knee pain in the MOST cohort: a 5-year longitudinal study. Osteoarthr. Cartil. 21, 1154–1159 (2013).

doi: 10.1016/j.joca.2013.05.016

Corrigan, P. et al. Relation of temporal asymmetry during walking to two-year knee pain outcomes in those with mild-to-moderate unilateral knee pain: an exploratory analysis from the Multicenter Osteoarthritis Study. Arthritis Care Res 75, 1735–1743 (2023).

doi: 10.1002/acr.25050

Zhaoyang, R. & Martire, L. M. Daily sedentary behavior predicts pain and affect in knee arthritis. Ann. Behav. Med. 53, 642–651 (2019).

pubmed: 30265286 doi: 10.1093/abm/kay073

Boer, C. G. et al. Intestinal microbiome composition and its relation to joint pain and inflammation. Nat. Commun. 10, 4881 (2019).

pubmed: 31653850 pmcid: 6814863 doi: 10.1038/s41467-019-12873-4

Alenazi, A. M. et al. Type 2 diabetes affects joint pain severity in people with localized osteoarthritis: a retrospective study. Pain. Med. 21, 1025–1031 (2020).

pubmed: 31710675 doi: 10.1093/pm/pnz299

Magnusson, K. et al. Diabetes is associated with increased hand pain in erosive hand osteoarthritis: data from a population-based study: hand pain in erosive versus nonerosive hand OA. Arthritis Care Res. 67, 187–195 (2015).

doi: 10.1002/acr.22460

Rehling, T., Bjørkman, A.-S. D., Andersen, M. B., Ekholm, O. & Molsted, S. Diabetes is associated with musculoskeletal pain, osteoarthritis, osteoporosis, and rheumatoid arthritis. J. Diabetes Res. 2019, 6324348 (2019).

pubmed: 31886282 pmcid: 6925775 doi: 10.1155/2019/6324348

Pan, F., Tian, J., Cicuttini, F. & Jones, G. Metabolic syndrome and trajectory of knee pain in older adults. Osteoarthr. Cartil. 28, 45–52 (2020).

doi: 10.1016/j.joca.2019.05.030

Boer, C. G. et al. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations. Cell 184, 4784–4818.e17 (2021).

pubmed: 34450027 pmcid: 8459317 doi: 10.1016/j.cell.2021.07.038

Gierach, M., Gierach, J., Ewertowska, M., Arndt, A. & Junik, R. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinol. 2014, 514589 (2014).

pubmed: 24729884 pmcid: 3960736 doi: 10.1155/2014/514589

Ganz, M. L. et al. The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. Diabetol. Metab. Syndr. 6, 50 (2014).

pubmed: 24694251 pmcid: 3976458 doi: 10.1186/1758-5996-6-50

Abbasi, A., Juszczyk, D., Van Jaarsveld, C. H. M. & Gulliford, M. C. Body-mass index and incidence of type 1 and type 2 diabetes in children and young adults in the UK: an observational cohort study. Lancet 388, S16 (2016).

doi: 10.1016/S0140-6736(16)32252-8

Liu, R. et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat. Med. 23, 859–868 (2017).

pubmed: 28628112 doi: 10.1038/nm.4358

Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840–846 (2006).

pubmed: 17167471 doi: 10.1038/nature05482

Veronese, N. et al. Mediterranean diet and knee osteoarthritis outcomes: a longitudinal cohort study. Clin. Nutr. 38, 2735–2739 (2019).

pubmed: 30553579 doi: 10.1016/j.clnu.2018.11.032

Zhao, G. et al. Depression and anxiety among US adults: associations with body mass index. Int. J. Obes. 33, 257–266 (2009).

doi: 10.1038/ijo.2008.268

Silva, D. A., Coutinho, E. D. S. F., Ferriani, L. O. & Viana, M. C. Depression subtypes and obesity in adults: a systematic review and meta‐analysis. Obes. Rev. 21, e12966 (2020).

pubmed: 31724325 doi: 10.1111/obr.12966

Campbell, S. D. I. et al. Sedentary behavior and body weight and composition in adults: a systematic review and meta-analysis of prospective studies. Sports Med. 48, 585–595 (2018).

pubmed: 29189928 doi: 10.1007/s40279-017-0828-6

Silveira, E. A. et al. Sedentary behavior, physical inactivity, abdominal obesity and obesity in adults and older adults: a systematic review and meta-analysis. Clin. Nutr. ESPEN 50, 63–73 (2022).

pubmed: 35871953 doi: 10.1016/j.clnesp.2022.06.001

Bollinger, L. M. & Ransom, A. L. The association of obesity with quadriceps activation during sit-to-stand. Phys. Ther. 100, 2134–2143 (2020).

pubmed: 32936920 doi: 10.1093/ptj/pzaa170

Sarkar, A., Bansal, N. & Singh, S. Effects of obesity on quadriceps dynamic strengthening and isometrics exercise for the treatment of knee osteoarthritis patients. Br. J. Sports Med. 44, i13–i14 (2010).

doi: 10.1136/bjsm.2010.078725.41

Boyce, L. et al. The outcomes of total knee arthroplasty in morbidly obese patients: a systematic review of the literature. Arch. Orthop. Trauma. Surg. 139, 553–560 (2019).

pubmed: 30778723 pmcid: 6420900 doi: 10.1007/s00402-019-03127-5

Martinez-Cano, J. P. et al. Body mass index and knee arthroplasty. J. Clin. Orthop. Trauma. 11, S711–S716 (2020).

pubmed: 32999544 pmcid: 7503064 doi: 10.1016/j.jcot.2020.06.015

Lincoln, K. D., Abdou, C. M. & Lloyd, D. Race and socioeconomic differences in obesity and depression among Black and non-Hispanic White Americans. J. Health Care Poor Underserved 25, 257–275 (2014).

pubmed: 24509025 pmcid: 4830390 doi: 10.1353/hpu.2014.0038

Lofton, H., Ard, J. D., Hunt, R. R. & Knight, M. G. Obesity among African American people in the United States: a review. Obesity 31, 306–315 (2023).

pubmed: 36695059 doi: 10.1002/oby.23640

Dong, H.-J., Larsson, B., Levin, L.-Å., Bernfort, L. & Gerdle, B. Is excess weight a burden for older adults who suffer chronic pain? BMC Geriatr. 18, 270 (2018).

pubmed: 30409125 pmcid: 6225711 doi: 10.1186/s12877-018-0963-4

Vennu, V., Alenazi, A. M., Abdulrahman, T. A., Binnasser, A. S. & Bindawas, S. M. Obesity and multisite pain in the lower limbs: data from the osteoarthritis initiative. Pain. Res. Manag. 2020, 6263505 (2020).

pubmed: 32695246 pmcid: 7368928 doi: 10.1155/2020/6263505

Karsdal, M. A. et al. Osteoarthritis – a case for personalized health care? Osteoarthr. Cartil. 22, 7–16 (2014).

doi: 10.1016/j.joca.2013.10.018

Raja, S. N. et al. The revised IASP definition of pain: concepts, challenges, and compromises. Pain 161, 1976–1982 (2020).

pubmed: 32694387 pmcid: 7680716 doi: 10.1097/j.pain.0000000000001939

Thakur, M., Dickenson, A. H. & Baron, R. Osteoarthritis pain: nociceptive or neuropathic? Nat. Rev. Rheumatol. 10, 374–380 (2014).

pubmed: 24686507 doi: 10.1038/nrrheum.2014.47

Kanthawang, T. et al. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: data from the osteoarthritis initiative. Skelet. Radiol. 50, 217–229 (2021).

doi: 10.1007/s00256-020-03550-5

Del Sordo, L. et al. Impaired efferocytosis by synovial macrophages in patients with knee osteoarthritis. Arthritis Rheumatol. 75, 685–696 (2023).

pubmed: 36448607 doi: 10.1002/art.42412

Miller, R. E., Miller, R. J. & Malfait, A.-M. Osteoarthritis joint pain: the cytokine connection. Cytokine 70, 185–193 (2014).

pubmed: 25066335 pmcid: 4254338 doi: 10.1016/j.cyto.2014.06.019

Miscio, G. et al. Obesity and peripheral neuropathy risk: a dangerous liaison. J. Peripher. Nerv. Syst. 10, 354–358 (2005).

pubmed: 16279984 doi: 10.1111/j.1085-9489.2005.00047.x

Kazamel, M., Stino, A. M. & Smith, A. G. Metabolic syndrome and peripheral neuropathy. Muscle Nerve 63, 285–293 (2021).

pubmed: 33098165 doi: 10.1002/mus.27086

Hochman, J. R., French, M. R., Bermingham, S. L. & Hawker, G. A. The nerve of osteoarthritis pain. Arthritis Care Res. 62, 1019–1023 (2010).

doi: 10.1002/acr.20142

Hozumi, J. et al. Relationship between neuropathic pain and obesity. Pain. Res. Manag. 2016, 2487924 (2016).

pubmed: 27445603 pmcid: 4904620 doi: 10.1155/2016/2487924

Güngör Demir, U., Demir, A. N. & Toraman, N. F. Neuropathic pain in knee osteoarthritis. Adv. Rheumatol. 61, 67 (2021).

pubmed: 34743761 doi: 10.1186/s42358-021-00225-0

WHO Consultation on Obesity. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Technical Report Series 894 (WHO, 2000).

WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163 (2004).

doi: 10.1016/S0140-6736(03)15268-3

WHO Expert Committee. Physical status: the use and interpretation of anthropometry. Technical Report Series 854 (WHO, 1995).

Lam, B. C. C., Koh, G. C. H., Chen, C., Wong, M. T. K. & Fallows, S. J. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE 10, e0122985 (2015).

pubmed: 25880905 pmcid: 4400161 doi: 10.1371/journal.pone.0122985

Schutz, Y., Kyle, U. & Pichard, C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y. Int. J. Obes. 26, 953–960 (2002).

doi: 10.1038/sj.ijo.0802037

Mikkilineni, H. et al. Ultrasound evaluation of infrapatellar fat pad impingement: an exploratory prospective study. Knee 25, 279–285 (2018).

pubmed: 29525550 doi: 10.1016/j.knee.2018.01.008

Ramirez, M. E. Measurement of subcutaneous adipose tissue using ultrasound images. Am. J. Phys. Anthropol. 89, 347–357 (1992).

pubmed: 1485642 doi: 10.1002/ajpa.1330890308

Klopfenstein, B. J. et al. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br. J. Radiol. 85, e826–e830 (2012).

pubmed: 22514099 pmcid: 3474042 doi: 10.1259/bjr/57987644

Bucerius, J. et al. Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study. Eur. J. Nucl. Med. Mol. Imaging 41, 934–945 (2014).

pubmed: 24442596 pmcid: 4024167 doi: 10.1007/s00259-013-2653-y

Walsh, T. P. et al. The association between body fat and musculoskeletal pain: a systematic review and meta-analysis. BMC Musculoskelet. Disord. 19, 233 (2018).

pubmed: 30021590 pmcid: 6052598 doi: 10.1186/s12891-018-2137-0

Visser, A. W. et al. The role of fat mass and skeletal muscle mass in knee osteoarthritis is different for men and women: the NEO study. Osteoarthr. Cartil. 22, 197–202 (2014).

doi: 10.1016/j.joca.2013.12.002

Yoo, J. J., Cho, N. H., Lim, S. H. & Kim, H. A. Relationships between body mass index, fat mass, muscle mass, and musculoskeletal pain in community residents: increased body fat mass and musculoskeletal pain. Arthritis Rheumatol. 66, 3511–3520 (2014).

pubmed: 25185757 doi: 10.1002/art.38861

Jin, X. et al. Longitudinal associations between adiposity and change in knee pain: Tasmanian older adult cohort study. Semin. Arthritis Rheum. 45, 564–569 (2016).

pubmed: 26596913 doi: 10.1016/j.semarthrit.2015.10.006

Kim, H. I. et al. Effects of sarcopenia and sarcopenic obesity on joint pain and degenerative osteoarthritis in postmenopausal women. Sci. Rep. 12, 13543 (2022).

pubmed: 35945253 pmcid: 9363497 doi: 10.1038/s41598-022-17451-1

Jeanmaire, C. et al. Body composition and clinical symptoms in patients with hip or knee osteoarthritis: results from the KHOALA cohort. Semin. Arthritis Rheum. 47, 797–804 (2018).

pubmed: 29224976 doi: 10.1016/j.semarthrit.2017.10.012

Godziuk, K., Prado, C. M., Woodhouse, L. J. & Forhan, M. The impact of sarcopenic obesity on knee and hip osteoarthritis: a scoping review. BMC Musculoskelet. Disord. 19, 271 (2018).

pubmed: 30055599 pmcid: 6064616 doi: 10.1186/s12891-018-2175-7

Knoop, J. et al. Identification of phenotypes with different clinical outcomes in knee osteoarthritis: data from the osteoarthritis initiative. Arthritis Care Res. 63, 1535–1542 (2011).

doi: 10.1002/acr.20571

Ribeiro Rosa, K. et al. Role of central obesity on pain onset and its association with cardiovascular disease: a retrospective study of a hospital cohort of patients with osteoarthritis. BMJ Open 12, e066453 (2022).

pubmed: 36564108 pmcid: 9791386 doi: 10.1136/bmjopen-2022-066453

Lohmander, L. S., Gerhardsson de Verdier, M., Rollof, J., Nilsson, P. M. & Engström, G. Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study. Ann. Rheum. Dis. 68, 490–496 (2009).

pubmed: 18467514 doi: 10.1136/ard.2008.089748

Li, S. et al. Association of visceral adiposity with pain but not structural osteoarthritis. Arthritis Rheumatol. 72, 1103–1110 (2020).

pubmed: 32039565 pmcid: 7329601 doi: 10.1002/art.41222

Leitner, B. P. et al. Mapping of human brown adipose tissue in lean and obese young men. Proc. Natl Acad. Sci. USA 114, 8649–8654 (2017).

pubmed: 28739898 pmcid: 5559032 doi: 10.1073/pnas.1705287114

Britton, K. A. et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J. Am. Coll. Cardiol. 62, 921–925 (2013).

pubmed: 23850922 pmcid: 4142485 doi: 10.1016/j.jacc.2013.06.027

Wajchenberg, B. L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697–738 (2000).

pubmed: 11133069 doi: 10.1210/edrv.21.6.0415

Zapata-Linares, N., Eymard, F., Berenbaum, F. & Houard, X. Role of adipose tissues in osteoarthritis. Curr. Opin. Rheumatol. 33, 84–93 (2021).

pubmed: 33186248 doi: 10.1097/BOR.0000000000000763

Eymard, F. et al. Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis. Ann. Rheum. Dis. 76, 1142–1148 (2017).

pubmed: 28298375 doi: 10.1136/annrheumdis-2016-210478

Silva, K. R. et al. Characterization of stromal vascular fraction and adipose stem cells from subcutaneous, preperitoneal and visceral morbidly obese human adipose tissue depots. PLoS ONE 12, e0174115 (2017).

pubmed: 28323901 pmcid: 5360317 doi: 10.1371/journal.pone.0174115

Sakers, A., De Siqueira, M. K., Seale, P. & Villanueva, C. J. Adipose-tissue plasticity in health and disease. Cell 185, 419–446 (2022).

pubmed: 35120662 pmcid: 11152570 doi: 10.1016/j.cell.2021.12.016

Scheja, L. & Heeren, J. The endocrine function of adipose tissues in health and cardiometabolic disease. Nat. Rev. Endocrinol. 15, 507–524 (2019).

pubmed: 31296970 doi: 10.1038/s41574-019-0230-6

Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I. & Kim, J. B. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front. Endocrinol. 7, 30 (2016).

doi: 10.3389/fendo.2016.00030

Nance, S. A., Muir, L. & Lumeng, C. Adipose tissue macrophages: regulators of adipose tissue immunometabolism during obesity. Mol. Metab. 66, 101642 (2022).

pubmed: 36402403 pmcid: 9703629 doi: 10.1016/j.molmet.2022.101642

Yao, J., Wu, D. & Qiu, Y. Adipose tissue macrophage in obesity-associated metabolic diseases. Front. Immunol. 13, 977485 (2022).

pubmed: 36119080 pmcid: 9478335 doi: 10.3389/fimmu.2022.977485

Morigny, P., Boucher, J., Arner, P. & Langin, D. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat. Rev. Endocrinol. 17, 276–295 (2021).

pubmed: 33627836 doi: 10.1038/s41574-021-00471-8

Longo, M. et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int. J. Mol. Sci. 20, 2358 (2019).

pubmed: 31085992 pmcid: 6539070 doi: 10.3390/ijms20092358

Hajer, G. R., Van Haeften, T. W. & Visseren, F. L. J. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 29, 2959–2971 (2008).

pubmed: 18775919 doi: 10.1093/eurheartj/ehn387

Blüher, M. Adipose tissue dysfunction in obesity. Exp. Clin. Endocrinol. Diabetes 117, 241–250 (2009).

pubmed: 19358089 doi: 10.1055/s-0029-1192044

Tchernof, A. & Després, J.-P. Pathophysiology of human visceral obesity: an update. Physiol. Rev. 93, 359–404 (2013).

pubmed: 23303913 doi: 10.1152/physrev.00033.2011

Horwich, T. B., Fonarow, G. C. & Clark, A. L. Obesity and the obesity paradox in heart failure. Prog. Cardiovasc. Dis. 61, 151–156 (2018).

pubmed: 29852198 doi: 10.1016/j.pcad.2018.05.005

Elagizi, A. et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog. Cardiovasc. Dis. 61, 142–150 (2018).

pubmed: 29981771 doi: 10.1016/j.pcad.2018.07.003

Bosello, O. & Vanzo, A. Obesity paradox and aging. Eat. Weight Disord. 26, 27–35 (2021).

pubmed: 31865598 doi: 10.1007/s40519-019-00815-4

Hassan, M., Latif, N. & Yacoub, M. Adipose tissue: friend or foe? Nat. Rev. Cardiol. 9, 689–702 (2012).

pubmed: 23149834 doi: 10.1038/nrcardio.2012.148

Chang, J. et al. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthr. Cartil. 26, 864–871 (2018).

doi: 10.1016/j.joca.2018.03.004

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001).

doi: 10.1001/jama.285.19.2486

Puenpatom, R. A. & Victor, T. W. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad. Med. 121, 9–20 (2009).

pubmed: 19940413 doi: 10.3810/pgm.2009.11.2073

Courties, A., Sellam, J. & Berenbaum, F. Metabolic syndrome-associated osteoarthritis. Curr. Opin. Rheumatol. 29, 214–222 (2017).

pubmed: 28072592 doi: 10.1097/BOR.0000000000000373

Courties, A., Berenbaum, F. & Sellam, J. The phenotypic approach to osteoarthritis: a look at metabolic syndrome-associated osteoarthritis. Jt Bone Spine 86, 725–730 (2019).

doi: 10.1016/j.jbspin.2018.12.005

Courties, A., Gualillo, O., Berenbaum, F. & Sellam, J. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthr. Cartil. 23, 1955–1965 (2015).

doi: 10.1016/j.joca.2015.05.016

Tomi, A.-L. et al. Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study. Ann. Rheum. Dis. 75, 2101–2107 (2016).

pubmed: 27034453 doi: 10.1136/annrheumdis-2016-209262

Visser, A. W. et al. The relative contribution of mechanical stress and systemic processes in different types of osteoarthritis: the NEO study. Ann. Rheum. Dis. 74, 1842–1847 (2015).

pubmed: 24845389 doi: 10.1136/annrheumdis-2013-205012

Berenbaum, F., Griffin, T. M. & Liu‐Bryan, R. Review: metabolic regulation of inflammation in osteoarthritis. Arthritis Rheumatol. 69, 9–21 (2017).

pubmed: 27564539 pmcid: 5341385 doi: 10.1002/art.39842

Niu, J., Clancy, M., Aliabadi, P., Vasan, R. & Felson, D. T. Metabolic syndrome, its components, and knee osteoarthritis: the Framingham Osteoarthritis Study. Arthritis Rheumatol. 69, 1194–1203 (2017).

pubmed: 28257604 pmcid: 5449217 doi: 10.1002/art.40087

Charton, A. et al. Metabolic syndrome is associated with more pain in hand osteoarthritis: results from the DIGICOD cohort. Ann. Rheum. Dis. 82, 1038 abstr. POS1370 (2023).

Sanchez-Santos, M. et al. Association of metabolic syndrome with knee and hand osteoarthritis: a community-based study of women. Semin. Arthritis Rheum. 48, 791–798 (2019).

pubmed: 30172470 doi: 10.1016/j.semarthrit.2018.07.007

Afifi, A. E.-M. A. et al. Osteoarthritis of knee joint in metabolic syndrome. Clin. Rheumatol. 37, 2855–2861 (2018).

pubmed: 30039268 doi: 10.1007/s10067-018-4201-4

Abourazzak, F. et al. Does metabolic syndrome or its individual components affect pain and function in knee osteoarthritis women? Curr. Rheumatol. Rev. 11, 8–14 (2015).

pubmed: 29052495 doi: 10.2174/1573397111666150522093337

Shin, D. Association between metabolic syndrome, radiographic knee osteoarthritis, and intensity of knee pain: results of a national survey. J. Clin. Endocrinol. Metab. 99, 3177–3183 (2014).

pubmed: 24780047 doi: 10.1210/jc.2014-1043

Sowers, M. et al. Knee osteoarthritis in obese women with cardiometabolic clustering. Arthritis Rheum. 61, 1328–1336 (2009).

pubmed: 19790111 pmcid: 2776774 doi: 10.1002/art.24739

Li, H., George, D. M., Jaarsma, R. L. & Mao, X. Metabolic syndrome and components exacerbate osteoarthritis symptoms of pain, depression and reduced knee function. Ann. Transl. Med. 4, 133–133 (2016).

pubmed: 27162783 pmcid: 4842398 doi: 10.21037/atm.2016.03.48

Courties, A. & Sellam, J. Osteoarthritis and type 2 diabetes mellitus: what are the links? Diabetes Res. Clin. Pract. 122, 198–206 (2016).

pubmed: 27889689 doi: 10.1016/j.diabres.2016.10.021

Louati, K., Vidal, C., Berenbaum, F. & Sellam, J. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open. 1, e000077 (2015).

pubmed: 26535137 pmcid: 4613158 doi: 10.1136/rmdopen-2015-000077

Williams, M. F., London, D. A., Husni, E. M., Navaneethan, S. & Kashyap, S. R. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J. Diabetes Complications 30, 944–950 (2016).

pubmed: 27114387 doi: 10.1016/j.jdiacomp.2016.02.016

Schett, G. et al. Diabetes is an independent predictor for severe osteoarthritis. Diabetes Care 36, 403–409 (2013).

pubmed: 23002084 pmcid: 3554306 doi: 10.2337/dc12-0924

Eitner, A., Culvenor, A. G., Wirth, W., Schaible, H. & Eckstein, F. Impact of diabetes mellitus on knee osteoarthritis pain and physical and mental status: data from the osteoarthritis initiative. Arthritis Care Res. 73, 540–548 (2021).

doi: 10.1002/acr.24173

Charen, D. A., Solomon, D., Zubizarreta, N., Poeran, J. & Colvin, A. C. Examining the association of knee pain with modifiable cardiometabolic risk factors. Arthritis Care Res. 73, 1777–1783 (2021).

doi: 10.1002/acr.24423

Alenazi, A. M. et al. The association of diabetes with knee pain severity and distribution in people with knee osteoarthritis using data from the osteoarthritis initiative. Sci. Rep. 10, 3985 (2020).

pubmed: 32132621 pmcid: 7055209 doi: 10.1038/s41598-020-60989-1

Banks, S. E., Riley, T. R. & Naides, S. J. Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease. Dig. Dis. Sci. 52, 1177–1182 (2007).

pubmed: 17387612 doi: 10.1007/s10620-006-9109-7

Baudart, P., Louati, K., Marcelli, C., Berenbaum, F. & Sellam, J. Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis. RMD Open. 3, e000442 (2017).

pubmed: 29435358 pmcid: 5706481 doi: 10.1136/rmdopen-2017-000442

Xiong, J., Long, J., Chen, X., Li, Y. & Song, H. Dyslipidemia might be associated with an increased risk of osteoarthritis. BioMed Res. Int. 2020, 3105248 (2020).

pubmed: 32149100 pmcid: 7048911 doi: 10.1155/2020/3105248

Lo, K., Au, M., Ni, J. & Wen, C. Association between hypertension and osteoarthritis: a systematic review and meta-analysis of observational studies. J. Orthop. Transl. 32, 12–20 (2022).

Zhou, M. et al. The cross-sectional and longitudinal effect of hyperlipidemia on knee osteoarthritis: results from the Dongfeng-Tongji cohort in China. Sci. Rep. 7, 9739 (2017).

pubmed: 28852192 pmcid: 5575029 doi: 10.1038/s41598-017-10158-8

Cho, B. W. et al. Cross-sectional association between hypercholesterolemia and knee pain in the elderly with radiographic knee osteoarthritis: data from the Korean National Health and Nutritional Examination Survey. J. Clin. Med. 10, 933 (2021).

pubmed: 33804313 pmcid: 7957475 doi: 10.3390/jcm10050933

Schwager, J. L. et al. Association of serum low-density lipoprotein, high-density lipoprotein, and total cholesterol with development of knee osteoarthritis. Arthritis Care Res. 74, 274–280 (2022).

doi: 10.1002/acr.24455

Dabke, K., Hendrick, G. & Devkota, S. The gut microbiome and metabolic syndrome. J. Clin. Invest. 129, 4050–4057 (2019).

pubmed: 31573550 pmcid: 6763239 doi: 10.1172/JCI129194

Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K. & Dumas, M.-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 8, 42 (2016).

pubmed: 27098727 pmcid: 4839080 doi: 10.1186/s13073-016-0303-2

Kim, M.-H. et al. Gut microbiota and metabolic health among overweight and obese individuals. Sci. Rep. 10, 19417 (2020).

pubmed: 33173145 pmcid: 7655835 doi: 10.1038/s41598-020-76474-8

Wu, J. et al. Associations between serum ghrelin and knee symptoms, joint structures and cartilage or bone biomarkers in patients with knee osteoarthritis. Osteoarthr. Cartil. 25, 1428–1435 (2017).

doi: 10.1016/j.joca.2017.05.015

Guss, J. D. et al. The effects of metabolic syndrome, obesity, and the gut microbiome on load-induced osteoarthritis. Osteoarthr. Cartil. 27, 129–139 (2019).

doi: 10.1016/j.joca.2018.07.020

Chisari, E., Wouthuyzen-Bakker, M., Friedrich, A. W. & Parvizi, J. The relation between the gut microbiome and osteoarthritis: a systematic review of literature. PLoS ONE 16, e0261353 (2021).

pubmed: 34914764 pmcid: 8675674 doi: 10.1371/journal.pone.0261353

Collins, K. H., Schwartz, D. J., Lenz, K. L., Harris, C. A. & Guilak, F. Taxonomic changes in the gut microbiota are associated with cartilage damage independent of adiposity, high fat diet, and joint injury. Sci. Rep. 11, 14560 (2021).

pubmed: 34267289 pmcid: 8282619 doi: 10.1038/s41598-021-94125-4

Loeser, R. F. et al. Association of increased serum lipopolysaccharide, but not microbial dysbiosis, with obesity-related osteoarthritis. Arthritis Rheumatol. 74, 227–236 (2022).

pubmed: 34423918 pmcid: 8795472 doi: 10.1002/art.41955

Griffin, T. M. et al. Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res. Ther. 12, R130 (2010).

pubmed: 20604941 pmcid: 2945020 doi: 10.1186/ar3068

Song, Z. et al. High-fat diet increases pain behaviors in rats with or without obesity. Sci. Rep. 7, 10350 (2017).

pubmed: 28871134 pmcid: 5583349 doi: 10.1038/s41598-017-10458-z

Huang, Z. Y., Stabler, T., Pei, F. X. & Kraus, V. B. Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation. Osteoarthr. Cartil. 24, 1769–1775 (2016).

doi: 10.1016/j.joca.2016.05.008

Binvignat, M. et al. Serum tryptophan metabolites are associated with erosive hand osteoarthritis and pain: results from the DIGICOD cohort. Osteoarthr. Cartil. 31, 1132–1143 (2023).

doi: 10.1016/j.joca.2023.04.007

Tilg, H. & Moschen, A. R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772–783 (2006).

pubmed: 16998510 doi: 10.1038/nri1937

Lönnqvist, F. et al. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J. Clin. Invest. 99, 2398–2404 (1997).

pubmed: 9153282 pmcid: 508079 doi: 10.1172/JCI119422

Pan, W. W. & Myers, M. G. Leptin and the maintenance of elevated body weight. Nat. Rev. Neurosci. 19, 95–105 (2018).

pubmed: 29321684 doi: 10.1038/nrn.2017.168

Straub, L. G. & Scherer, P. E. Metabolic messengers: adiponectin. Nat. Metab. 1, 334–339 (2019).

pubmed: 32661510 pmcid: 7357716 doi: 10.1038/s42255-019-0041-z

Ghadge, A. A. & Khaire, A. A. Leptin as a predictive marker for metabolic syndrome. Cytokine 121, 154735 (2019).

pubmed: 31154250 doi: 10.1016/j.cyto.2019.154735

Ahl, S. et al. Adiponectin levels differentiate metabolically healthy vs unhealthy among obese and nonobese white individuals. J. Clin. Endocrinol. Metab. 100, 4172–4180 (2015).

pubmed: 26401592 pmcid: 4702448 doi: 10.1210/jc.2015-2765

Gariballa, S., Alkaabi, J., Yasin, J. & Al Essa, A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr. Disord. 19, 55 (2019).

pubmed: 31159801 pmcid: 6545728 doi: 10.1186/s12902-019-0386-z

Li, S., Shin, H. J., Ding, E. L. & Van Dam, R. M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302, 179–188 (2009).

pubmed: 19584347 doi: 10.1001/jama.2009.976

Korac, A. et al. Adipokine signatures of subcutaneous and visceral abdominal fat in normal-weight and obese women with different metabolic profiles. Arch. Med. Sci. 17, 323–336 (2021).

pubmed: 33747267 pmcid: 7959090 doi: 10.5114/aoms/92118

Van Harmelen, V. et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47, 913–917 (1998).

pubmed: 9604868 doi: 10.2337/diabetes.47.6.913

Frühbeck, G., Catalán, V., Rodríguez, A. & Gómez-Ambrosi, J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte 7, 57–62 (2018).

pubmed: 29205099 doi: 10.1080/21623945.2017.1402151

Frühbeck, G. et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients 11, 454 (2019).

pubmed: 30813240 pmcid: 6412349 doi: 10.3390/nu11020454

Hu, Z.-J. et al. Peripheral leptin signaling mediates formalin-induced nociception. Neurosci. Bull. 34, 321–329 (2018).

pubmed: 29204732 doi: 10.1007/s12264-017-0194-2

Sun, L., Li, H., Tai, L. W., Gu, P. & Cheung, C. W. Adiponectin regulates thermal nociception in a mouse model of neuropathic pain. Br. J. Anaesth. 120, 1356–1367 (2018).

pubmed: 29793601 doi: 10.1016/j.bja.2018.01.016

De Boer, T. N. et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthr. Cartil. 20, 846–853 (2012).

doi: 10.1016/j.joca.2012.05.002

Hülser, M.-L. et al. Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse model. Sci. Rep. 11, 17001 (2021).

pubmed: 34417537 pmcid: 8379250 doi: 10.1038/s41598-021-96545-8

Azamar-Llamas, D., Hernández-Molina, G., Ramos-Ávalos, B. & Furuzawa-Carballeda, J. Adipokine contribution to the pathogenesis of osteoarthritis. Mediators Inflamm. 2017, 5468023 (2017).

pubmed: 28490838 pmcid: 5401756 doi: 10.1155/2017/5468023

Martel-Pelletier, J., Raynauld, J.-P., Dorais, M., Abram, F. & Pelletier, J.-P. The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis. Rheumatology 55, 680–688 (2016).

pubmed: 26660640 doi: 10.1093/rheumatology/kev408

Zhu, J. et al. Association of serum levels of inflammatory markers and adipokines with joint symptoms and structures in participants with knee osteoarthritis. Rheumatology 61, 1044–1052 (2022).

pubmed: 34114615 doi: 10.1093/rheumatology/keab479

Conde, J. et al. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann. Rheum. Dis. 73, 631–633 (2014).

pubmed: 24099837 doi: 10.1136/annrheumdis-2013-204189

Kroon, F. P. B. et al. The role of leptin and adiponectin as mediators in the relationship between adiposity and hand and knee osteoarthritis. Osteoarthr. Cartil. 27, 1761–1767 (2019).

doi: 10.1016/j.joca.2019.08.003

Yusuf, E. et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann. Rheum. Dis. 70, 1282–1284 (2011).

pubmed: 21470970 doi: 10.1136/ard.2010.146282

Stannus, O. P. et al. Cross-sectional and longitudinal associations between circulating leptin and knee cartilage thickness in older adults. Ann. Rheum. Dis. 74, 82–88 (2015).

pubmed: 24078677 doi: 10.1136/annrheumdis-2013-203308

Stannus, O. P. et al. The association between leptin, interleukin-6, and hip radiographic osteoarthritis in older people: a cross-sectional study. Arthritis Res. Ther. 12, R95 (2010).

pubmed: 20482813 pmcid: 2911879 doi: 10.1186/ar3022

Orellana, C. et al. Synovial adiponectin was more associated with clinical severity than synovial leptin in women with knee osteoarthritis. Cartilage 13, 1675S–1683S (2021).

pubmed: 32079412 doi: 10.1177/1947603520904776

Sellam, J. et al. Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: cross-sectional results of the KHOALA cohort. Semin. Arthritis Rheum. 51, 129–136 (2021).

pubmed: 33383288 doi: 10.1016/j.semarthrit.2020.10.004

Askari, A. et al. The role of adipose tissue secretion in the creation and pain level in osteoarthritis. Endocr. Regul. 54, 6–13 (2020).

pubmed: 32597150 doi: 10.2478/enr-2020-0002

Bas, S. et al. Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee. Int. Orthop. 38, 2577–2583 (2014).

pubmed: 25005460 doi: 10.1007/s00264-014-2416-9

Perruccio, A. V., Mahomed, N. N., Chandran, V. & Gandhi, R. Plasma adipokine levels and their association with overall burden of painful joints among individuals with hip and knee osteoarthritis. J. Rheumatol. 41, 334–337 (2014).

pubmed: 24334649 doi: 10.3899/jrheum.130709

Calvet, J. et al. Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: a cross-sectional study in female patients with joint effusion. Arthritis Res. Ther. 18, 207 (2016).

pubmed: 27629533 pmcid: 5024464 doi: 10.1186/s13075-016-1103-1

Calvet, J. et al. Differential involvement of synovial adipokines in pain and physical function in female patients with knee osteoarthritis. A cross-sectional study. Osteoarthr. Cartil. 26, 276–284 (2018).

doi: 10.1016/j.joca.2017.11.010

Gandhi, R. et al. Obesity-related adipokines predict patient-reported shoulder pain. Obes. Facts 6, 536–541 (2013).

pubmed: 24335140 pmcid: 5644779 doi: 10.1159/000357230

Massengale, M., Lu, B., Pan, J. J., Katz, J. N. & Solomon, D. H. Adipokine hormones and hand osteoarthritis: radiographic severity and pain. PLoS ONE 7, e47860 (2012).

pubmed: 23110114 pmcid: 3482224 doi: 10.1371/journal.pone.0047860

Lübbeke, A. et al. Do synovial leptin levels correlate with pain in end stage arthritis? Int. Orthop. 37, 2071–2079 (2013).

pubmed: 23835555 pmcid: 3779572 doi: 10.1007/s00264-013-1982-6

Gundogdu, G., Gundogdu, K., Miloglu, F. D. & Tascı, S. Y. A new perspective on the relation between obesity and knee osteoarthritis: omentin. Curr. Rheumatol. Rev. 16, 324–331 (2020).

pubmed: 31878858 doi: 10.2174/1573397116666191226122801

van Andel, M., Heijboer, A. C. & Drent, M. L. Adiponectin and its isoforms in pathophysiology. Adv. Clin. Chem. 85, 115–147 (2018).

pubmed: 29655459 doi: 10.1016/bs.acc.2018.02.007

Hensellek, S., Brell, P., Schaible, H.-G., Bräuer, R. & Segond Von Banchet, G. The cytokine TNFα increases the proportion of DRG neurones expressing the TRPV1 receptor via the TNFR1 receptor and ERK activation. Mol. Cell. Neurosci. 36, 381–391 (2007).

pubmed: 17851089 doi: 10.1016/j.mcn.2007.07.010

Ebbinghaus, M. et al. The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis. Arthritis Rheum. 64, 3897–3907 (2012).

pubmed: 22933159 doi: 10.1002/art.34675

Abdalla, M. M. I. Role of visfatin in obesity-induced insulin resistance. World J. Clin. Cases 10, 10840–10851 (2022).

pubmed: 36338223 pmcid: 9631142 doi: 10.12998/wjcc.v10.i30.10840

Benomar, Y. et al. Central resistin/TLR4 impairs adiponectin signaling, contributing to insulin and FGF21 resistance. Diabetes 65, 913–926 (2016).

pubmed: 26740596 doi: 10.2337/db15-1029

Song, Y. et al. Possible involvement of serum and synovial fluid resistin in knee osteoarthritis: cartilage damage, clinical, and radiological links: possible involvement links. J. Clin. Lab. Anal. 30, 437–443 (2016).

pubmed: 26494484 doi: 10.1002/jcla.21876

Franco-Trepat, E. et al. Visfatin connection: present and future in osteoarthritis and osteoporosis. J. Clin. Med. 8, 1178 (2019).

pubmed: 31394795 pmcid: 6723538 doi: 10.3390/jcm8081178

Martel-Pelletier, J. et al. The ratio adipsin/MCP-1 is strongly associated with structural changes and CRP/MCP-1 with symptoms in obese knee osteoarthritis subjects: data from the Osteoarthritis Initiative. Osteoarthr. Cartil. 27, 1163–1173 (2019).

doi: 10.1016/j.joca.2019.04.016

Lambova, S. N. et al. Serum leptin and resistin levels in knee osteoarthritis – clinical and radiologic links: towards precise definition of metabolic type knee osteoarthritis. Biomedicines 9, 1019 (2021).

pubmed: 34440223 pmcid: 8393571 doi: 10.3390/biomedicines9081019

Trim, W. V. & Lynch, L. Immune and non-immune functions of adipose tissue leukocytes. Nat. Rev. Immunol. 22, 371–386 (2022).

pubmed: 34741167 doi: 10.1038/s41577-021-00635-7

Guzik, T. J., Skiba, D. S., Touyz, R. M. & Harrison, D. G. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc. Res. 113, 1009–1023 (2017).

pubmed: 28838042 pmcid: 5852626 doi: 10.1093/cvr/cvx108

Kane, H. & Lynch, L. Innate immune control of adipose tissue homeostasis. Trends Immunol. 40, 857–872 (2019).

pubmed: 31399336 doi: 10.1016/j.it.2019.07.006

Harasymowicz, N. S. et al. Regional differences between perisynovial and infrapatellar adipose tissue depots and their response to class II and class III obesity in patients with osteoarthritis: response of OA knee adipose tissue deposits to obesity. Arthritis Rheumatol. 69, 1396–1406 (2017).

pubmed: 28320058 doi: 10.1002/art.40102

Daghestani, H. N., Pieper, C. F. & Kraus, V. B. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis: macrophage markers in OA. Arthritis Rheumatol. 67, 956–965 (2015).

pubmed: 25544994 pmcid: 4441094 doi: 10.1002/art.39006

Kraus, V. B. et al. Direct in vivo evidence of activated macrophages in human osteoarthritis. Osteoarthr. Cartil. 24, 1613–1621 (2016).

doi: 10.1016/j.joca.2016.04.010

Sakurai, Y. et al. Contribution of synovial macrophages to rat advanced osteoarthritis pain resistant to cyclooxygenase inhibitors. Pain 160, 895–907 (2019).

pubmed: 30585984 doi: 10.1097/j.pain.0000000000001466

Li, L. et al. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis. BMC Musculoskelet. Disord. 21, 99 (2020).

pubmed: 32059658 pmcid: 7023718 doi: 10.1186/s12891-020-3120-0

Attur, M. et al. Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum. 63, 1908–1917 (2011).

pubmed: 21717421 pmcid: 3128429 doi: 10.1002/art.30360

Richette, P. et al. A high interleukin 1 receptor antagonist/IL-1β ratio occurs naturally in knee osteoarthritis. J. Rheumatol. 35, 1650–1654 (2008).

pubmed: 18597398

Pan, F., Tian, J., Cicuttini, F. & Jones, G. Prospective association between inflammatory markers and knee cartilage volume loss and pain trajectory. Pain. Ther. 11, 107–119 (2022).

pubmed: 34837639 doi: 10.1007/s40122-021-00341-1

Stannus, O. P., Jones, G., Blizzard, L., Cicuttini, F. M. & Ding, C. Associations between serum levels of inflammatory markers and change in knee pain over 5 years in older adults: a prospective cohort study. Ann. Rheum. Dis. 72, 535–540 (2013).

pubmed: 22580582 doi: 10.1136/annrheumdis-2011-201047

Jin, X. et al. Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann. Rheum. Dis. 74, 703–710 (2015).

pubmed: 24363360 doi: 10.1136/annrheumdis-2013-204494

Garnero, P. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann. Rheum. Dis. 60, 619–626 (2001).

pubmed: 11350852 pmcid: 1753666 doi: 10.1136/ard.60.6.619

Garnero, P. et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. J. Rheumatol. 32, 697–703 (2005).

pubmed: 15801028

Keenan, R. T., Swearingen, C. J. & Yazici, Y. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clin. Exp. Rheumatol. 26, 814–819 (2008).

pubmed: 19032813

Wolfe, F. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip. J. Rheumatol. 24, 1486–1488 (1997).

pubmed: 9263139

Sturmer, T. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann. Rheum. Dis. 63, 200–205 (2004).

pubmed: 14722211 pmcid: 1754873 doi: 10.1136/ard.2003.007674

Kolb, H. Obese visceral fat tissue inflammation: from protective to detrimental? BMC Med. 20, 494 (2022).

pubmed: 36575472 pmcid: 9795790 doi: 10.1186/s12916-022-02672-y

Li, D. & Wu, M. Pattern recognition receptors in health and diseases. Signal. Transduct. Target. Ther. 6, 291 (2021).

pubmed: 34344870 pmcid: 8333067 doi: 10.1038/s41392-021-00687-0

Nefla, M., Holzinger, D., Berenbaum, F. & Jacques, C. The danger from within: alarmins in arthritis. Nat. Rev. Rheumatol. 12, 669–683 (2016).

pubmed: 27733758 doi: 10.1038/nrrheum.2016.162

Miller, R. E., Tran, P. B., Ishihara, S., Miller, R. J. & Malfait, A.-M. DAMPs provide a link between joint tissue damage and pain through direct activation of TLR4 expressed by sensory neurons. Osteoarthr. Cartil. 22, S416–S417 abstr. 750 (2014).

doi: 10.1016/j.joca.2014.02.785

Blom, A. B. et al. The alarmins S100A8 and S100A9 mediate acute pain in experimental synovitis. Arthritis Res. Ther. 22, 199 (2020).

pubmed: 32854769 pmcid: 7457270 doi: 10.1186/s13075-020-02295-9

Ruan, G. et al. Associations between serum S100A8/S100A9 and knee symptoms, joint structures and cartilage enzymes in patients with knee osteoarthritis. Osteoarthr. Cartil. 27, 99–105 (2019).

doi: 10.1016/j.joca.2018.08.020

Alvarez-Curto, E. & Milligan, G. Metabolism meets immunity: the role of free fatty acid receptors in the immune system. Biochem. Pharmacol. 114, 3–13 (2016).

pubmed: 27002183 doi: 10.1016/j.bcp.2016.03.017

Calder, P. C. n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83, 1505S–1519S (2006).

pubmed: 16841861 doi: 10.1093/ajcn/83.6.1505S

Frommer, K. W. et al. Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann. Rheum. Dis. 74, 303–310 (2015).

pubmed: 24285492 doi: 10.1136/annrheumdis-2013-203755

Frommer, K. W. et al. Free fatty acids in bone pathophysiology of rheumatic diseases. Front. Immunol. 10, 2757 (2019).

pubmed: 31849953 pmcid: 6901602 doi: 10.3389/fimmu.2019.02757

Alvarez-Garcia, O., Rogers, N. H., Smith, R. G. & Lotz, M. K. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1: effects of palmitate on articular cartilage. Arthritis Rheumatol. 66, 1779–1788 (2014).

pubmed: 24591481 pmcid: 4077915 doi: 10.1002/art.38399

Pousinis, P. et al. Lipidomic identification of plasma lipids associated with pain behaviour and pathology in a mouse model of osteoarthritis. Metabolomics 16, 32 (2020).

pubmed: 32108917 pmcid: 7046574 doi: 10.1007/s11306-020-01652-8

Loef, M. et al. The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort. Osteoarthr. Cartil. 30, 1062–1069 (2022).

doi: 10.1016/j.joca.2022.05.008

Loef, M. et al. The association of plasma fatty acids with hand and knee osteoarthritis: the NEO study. Osteoarthr. Cartil. 28, 223–230 (2020).

doi: 10.1016/j.joca.2019.10.002

Felson, D. T. et al. Fatty acids and osteoarthritis: the MOST study. Osteoarthr. Cartil. 29, 973–978 (2021).

doi: 10.1016/j.joca.2021.03.006

Eymard, F. et al. Induction of an inflammatory and prodegradative phenotype in autologous fibroblast-like synoviocytes by the infrapatellar fat pad from patients with knee osteoarthritis. Arthritis Rheumatol. 66, 2165–2174 (2014).

pubmed: 24719336 doi: 10.1002/art.38657

Wang, K. et al. Quantitative signal intensity alteration in infrapatellar fat pad predicts incident radiographic osteoarthritis: the osteoarthritis initiative. Arthritis Care Res. 71, 30–38 (2019).

doi: 10.1002/acr.23577

Iwata, M. et al. Initial responses of articular tissues in a murine high-fat diet-induced osteoarthritis model: pivotal role of the IPFP as a cytokine fountain. PLoS ONE 8, e60706 (2013).

pubmed: 23593289 pmcid: 3625196 doi: 10.1371/journal.pone.0060706

Warmink, K. et al. High-fat feeding primes the mouse knee joint to develop osteoarthritis and pathologic infrapatellar fat pad changes after surgically induced injury. Osteoarthr. Cartil. 28, 593–602 (2020).

doi: 10.1016/j.joca.2020.03.008

Masaki, T. et al. Volume change in infrapatellar fat pad is associated not with obesity but with cartilage degeneration. J. Orthop. Res. 37, 593–600 (2019).

pubmed: 30537040 doi: 10.1002/jor.24201

De Jong, A. J. et al. Lack of high BMI-related features in adipocytes and inflammatory cells in the infrapatellar fat pad (IFP). Arthritis Res. Ther. 19, 186 (2017).

pubmed: 28800775 pmcid: 5553811 doi: 10.1186/s13075-017-1395-9

Cowan, S. M., Hart, H. F., Warden, S. J. & Crossley, K. M. Infrapatellar fat pad volume is greater in individuals with patellofemoral joint osteoarthritis and associated with pain. Rheumatol. Int. 35, 1439–1442 (2015).

pubmed: 25782586 doi: 10.1007/s00296-015-3250-0

Ye, C. et al. Influence of the infrapatellar fat pad resection during total knee arthroplasty: a systematic review and meta-analysis. PLoS ONE 11, e0163515 (2016).

pubmed: 27706208 pmcid: 5051736 doi: 10.1371/journal.pone.0163515

Teichtahl, A. J. et al. A large infrapatellar fat pad protects against knee pain and lateral tibial cartilage volume loss. Arthritis Res. Ther. 17, 318 (2015).

pubmed: 26555322 pmcid: 4641355 doi: 10.1186/s13075-015-0831-y

Clements, K. M. et al. Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis pain. Osteoarthr. Cartil. 17, 805–812 (2009).

doi: 10.1016/j.joca.2008.11.002

Inomata, K. et al. Time course analyses of structural changes in the infrapatellar fat pad and synovial membrane during inflammation-induced persistent pain development in rat knee joint. BMC Musculoskelet. Disord. 20, 8 (2019).

pubmed: 30611247 pmcid: 6320593 doi: 10.1186/s12891-018-2391-1

Ballegaard, C. et al. Knee pain and inflammation in the infrapatellar fat pad estimated by conventional and dynamic contrast-enhanced magnetic resonance imaging in obese patients with osteoarthritis: a cross-sectional study. Osteoarthr. Cartil. 22, 933–940 (2014).

doi: 10.1016/j.joca.2014.04.018

Tolpadi, A. A., Lee, J. J., Pedoia, V. & Majumdar, S. Deep learning predicts total knee replacement from magnetic resonance images. Sci. Rep. 10, 6371 (2020).

pubmed: 32286452 pmcid: 7156761 doi: 10.1038/s41598-020-63395-9

Han, W. et al. Signal intensity alteration in the infrapatellar fat pad at baseline for the prediction of knee symptoms and structure in older adults: a cohort study. Ann. Rheum. Dis. 75, 1783–1788 (2016).

pubmed: 26612337 doi: 10.1136/annrheumdis-2015-208360

Bohnsack, M. et al. Distribution of substance-P nerves inside the infrapatellar fat pad and the adjacent synovial tissue: a neurohistological approach to anterior knee pain syndrome. Arch. Orthop. Trauma. Surg. 125, 592–597 (2005).

pubmed: 15891922 doi: 10.1007/s00402-005-0796-4

Kouroupis, D. et al. Infrapatellar fat pad-derived MSC response to inflammation and fibrosis induces an immunomodulatory phenotype involving CD10-mediated substance P degradation. Sci. Rep. 9, 10864 (2019).

pubmed: 31350444 pmcid: 6659713 doi: 10.1038/s41598-019-47391-2

Distel, E. et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum. 60, 3374–3377 (2009).

pubmed: 19877065 doi: 10.1002/art.24881

Eymard, F. et al. Contribution of adipocyte precursors in the phenotypic specificity of intra-articular adipose tissues in knee osteoarthritis patients. Arthritis Res. Ther. 21, 252 (2019).

pubmed: 31775901 pmcid: 6882235 doi: 10.1186/s13075-019-2058-9

Cen, H. et al. Quantitative infrapatellar fat pad signal intensity alteration as an imaging biomarker of knee osteoarthritis progression. RMD Open. 9, e002565 (2023).

pubmed: 36697038 pmcid: 9884854 doi: 10.1136/rmdopen-2022-002565

Malfait, A.-M., Miller, R. E. & Block, J. A. Targeting neurotrophic factors: novel approaches to musculoskeletal pain. Pharmacol. Ther. 211, 107553 (2020).

pubmed: 32311372 pmcid: 7938761 doi: 10.1016/j.pharmthera.2020.107553

Alves, C. J. et al. Nociceptive mechanisms driving pain in a post-traumatic osteoarthritis mouse model. Sci. Rep. 10, 15271 (2020).

pubmed: 32943744 pmcid: 7499425 doi: 10.1038/s41598-020-72227-9

Marshall, K. W., Chiu, B. & Inman, R. D. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheum. 33, 87–90 (1990).

pubmed: 1689161 doi: 10.1002/art.1780330111

Pritchett, J. W. Substance P level in synovial fluid may predict pain relief after knee replacement. J. Bone Jt. Surg. Br. 79-B, 114–116 (1997).

doi: 10.1302/0301-620X.79B1.0790114

Karagiannides, I. & Pothoulakis, C. Substance P, obesity, and gut inflammation. Curr. Opin. Endocrinol. Diabetes Obes. 16, 47–52 (2009).

pubmed: 19104238 pmcid: 4404028 doi: 10.1097/MED.0b013e328321306c

Karagiannides, I. et al. Substance P as a novel anti-obesity target. Gastroenterology 134, 747–755.e1 (2008).

pubmed: 18325388 doi: 10.1053/j.gastro.2007.12.032

Zhang, W., Cline, M. A. & Gilbert, E. R. Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism. Nutr. Metab. 11, 27 (2014).

doi: 10.1186/1743-7075-11-27

Wang, L. et al. Levels of neuropeptide Y in synovial fluid relate to pain in patients with knee osteoarthritis. BMC Musculoskelet. Disord. 15, 319 (2014).

pubmed: 25262001 pmcid: 4195915 doi: 10.1186/1471-2474-15-319

Bulló, M., Peeraully, M. R., Trayhurn, P., Folch, J. & Salas-Salvadó, J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur. J. Endocrinol. 157, 303–310 (2007).

pubmed: 17766712 doi: 10.1530/EJE-06-0716

Baldini, M. et al. Synovial and serum levels of NGF in osteoarthritis and rheumatic diseases: a systematic review. J. Biol. Regul. Homeost. Agents 34 (5 Suppl. 1), 25–32 (2020).

pubmed: 33739001

Shang, X., Wang, Z. & Tao, H. Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain. Ther. Clin. Risk Manag. 13, 951–956 (2017).

pubmed: 28814877 pmcid: 5546917 doi: 10.2147/TCRM.S139814

Levinger, I. et al. BDNF, metabolic risk factors, and resistance training in middle-aged individuals. Med. Sci. Sports Exerc. 40, 535–541 (2008).

pubmed: 18379218 doi: 10.1249/MSS.0b013e31815dd057

Boyuk, B. et al. Relationship between levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus. J. Diabetes Res. 2014, 978143 (2014).

pubmed: 25587547 pmcid: 4283269 doi: 10.1155/2014/978143

Gowler, P. R. W. et al. Peripheral brain-derived neurotrophic factor contributes to chronic osteoarthritis joint pain. Pain 161, 61–73 (2020).

pubmed: 31479064 doi: 10.1097/j.pain.0000000000001694

Tashani, O. A., Astita, R., Sharp, D. & Johnson, M. I. Body mass index and distribution of body fat can influence sensory detection and pain sensitivity. Eur. J. Pain. 21, 1186–1196 (2017).

pubmed: 28263427 doi: 10.1002/ejp.1019

Arendt-Nielsen, L. et al. Sensitization in patients with painful knee osteoarthritis. Pain 149, 573–581 (2010).

pubmed: 20418016 doi: 10.1016/j.pain.2010.04.003

Suokas, A. K. et al. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis. Osteoarthr. Cartil. 20, 1075–1085 (2012).

doi: 10.1016/j.joca.2012.06.009

Lluch, E., Torres, R., Nijs, J. & Van Oosterwijck, J. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review: central sensitization in osteoarthritis pain. Eur. J. Pain. 18, 1367–1375 (2014).

pubmed: 24700605 doi: 10.1002/j.1532-2149.2014.499.x

Steen Pettersen, P. et al. Associations between joint pathologies and central sensitization in persons with hand osteoarthritis: results from the Nor-Hand study. Rheumatol. 61, 2316–2324 (2021).

doi: 10.1093/rheumatology/keab708

Neogi, T. et al. Association of joint inflammation with pain sensitization in knee osteoarthritis: the Multicenter Osteoarthritis Study. Arthritis Rheumatol. 68, 654–661 (2016).

pubmed: 26554395 pmcid: 4827020 doi: 10.1002/art.39488

Lee, Y. C. et al. Pain sensitivity and pain reactivity in osteoarthritis. Arthritis Care Res. 63, 320–327 (2010).

doi: 10.1002/acr.20373

Jafarzadeh, S. R. et al. Mediating role of bone marrow lesion, synovitis, pain sensitization, and depressive symptoms on knee pain improvement following substantial weight loss. Arthritis Rheumatol. 72, 420–427 (2020).

pubmed: 31562683 pmcid: 7050338 doi: 10.1002/art.41125

Stefanik, J. J. et al. Changes in pain sensitization after bariatric surgery. Arthritis Care Res. 70, 1525–1528 (2018).

doi: 10.1002/acr.23513

Jinks, C., Jordan, K. & Croft, P. Disabling knee pain – another consequence of obesity: results from a prospective cohort study. BMC Public Health 6, 258 (2006).

pubmed: 17052337 pmcid: 1635709 doi: 10.1186/1471-2458-6-258

Gudbergsen, H. et al. Weight loss is effective for symptomatic relief in obese subjects with knee osteoarthritis independently of joint damage severity assessed by high-field MRI and radiography. Osteoarthr. Cartil. 20, 495–502 (2012).

doi: 10.1016/j.joca.2012.02.639

Felson, D. T., Zhang, Y., Anthony, J. M., Naimark, A. & Anderson, J. J. Weight loss reduces the risk for symptomatic knee osteoarthritis in women: the Framingham Study. Ann. Intern. Med. 116, 535–539 (1992).

pubmed: 1543306 doi: 10.7326/0003-4819-116-7-535

Messier, S. P. et al. Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: the arthritis, diet, and activity promotion trial. Arthritis Rheum. 50, 1501–1510 (2004).

pubmed: 15146420 doi: 10.1002/art.20256

Messier, S. P. et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA 310, 1263–1273 (2013).

pubmed: 24065013 pmcid: 4450354 doi: 10.1001/jama.2013.277669

Christensen, R., Bartels, E. M., Astrup, A. & Bliddal, H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann. Rheum. Dis. 66, 433–439 (2006).

doi: 10.1136/ard.2006.065904

Jurado-Castro, J. M., Muñoz-López, M., Ledesma, A. S.-T. & Ranchal-Sanchez, A. Effectiveness of exercise in patients with overweight or obesity suffering from knee osteoarthritis: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health 19, 10510 (2022).

pubmed: 36078226 pmcid: 9518463 doi: 10.3390/ijerph191710510

Huebner, J. L. et al. Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation. Osteoarthr. Cartil. 24, 1528–1534 (2016).

doi: 10.1016/j.joca.2016.04.002

Somers, T. J. et al. Pain coping skills training and lifestyle behavioral weight management in patients with knee osteoarthritis: a randomized controlled study. Pain 153, 1199–1209 (2012).

pubmed: 22503223 pmcid: 3358356 doi: 10.1016/j.pain.2012.02.023

Messier, S. P. et al. Intentional weight loss in overweight and obese patients with knee osteoarthritis: is more better? Arthritis Care Res. 70, 1569–1575 (2018).

doi: 10.1002/acr.23608

Hall, M. et al. Effects of adding a diet intervention to exercise on hip osteoarthritis pain: protocol for the ECHO randomized controlled trial. BMC Musculoskelet. Disord. 23, 215 (2022).

pubmed: 35248012 pmcid: 8898434 doi: 10.1186/s12891-022-05128-9

Peltonen, M., Lindroos, A. K. & Torgerson, J. S. Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain 104, 549–557 (2003).

pubmed: 12927627 doi: 10.1016/S0304-3959(03)00091-5

Richette, P. et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Ann. Rheum. Dis. 70, 139–144 (2011).

pubmed: 20980288 doi: 10.1136/ard.2010.134015

Edwards, C. et al. The effects of bariatric surgery weight loss on knee pain in patients with osteoarthritis of the knee. Arthritis 2012, 504189 (2012).

pubmed: 23243506 pmcid: 3518076 doi: 10.1155/2012/504189

Hooper, M. M., Stellato, T. A., Hallowell, P. T., Seitz, B. A. & Moskowitz, R. W. Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int. J. Obes. 31, 114–120 (2007).

doi: 10.1038/sj.ijo.0803349

Fonseca Mora, M. C. et al. Reduction of invasive interventions in severely obese with osteoarthritis after bariatric surgery. Surg. Endosc. 34, 3606–3613 (2020).

pubmed: 31559579 doi: 10.1007/s00464-019-07138-6

Kolasinski, S. L. et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 72, 220–233 (2020).

pubmed: 31908163 pmcid: 10518852 doi: 10.1002/art.41142

Lee, W. H., Kramer, W. G. & Granville, G. E. The effect of obesity on acetaminophen pharmacokinetics in man. J. Clin. Pharmacol. 21, 284–287 (1981).

pubmed: 7263926 doi: 10.1002/j.1552-4604.1981.tb01768.x

Pelletier, J.-P., Martel-Pelletier, J., Rannou, F. & Cooper, C. Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: evidence from real-life setting trials and surveys. Semin. Arthritis Rheum. 45, S22–S27 (2016).

pubmed: 26806184 doi: 10.1016/j.semarthrit.2015.11.009

Seefried, L. et al. Penetration of topical diclofenac into synovial tissue and fluid of osteoarthritic knees: a multicenter, randomized, placebo-controlled, pharmacokinetic study. Ther. Adv. Musculoskelet. Dis. 12, 1759720X20943088 (2020).

pubmed: 32922524 pmcid: 7457412 doi: 10.1177/1759720X20943088

Stokes, A. et al. Association of obesity with prescription opioids for painful conditions in patients seeking primary care in the US. JAMA Netw. Open 3, e202012 (2020).

pubmed: 32239222 pmcid: 7118518 doi: 10.1001/jamanetworkopen.2020.2012

Baghbani-Naghadehi, F., Armijo-Olivo, S., Prado, C. M., Gramlich, L. & Woodhouse, L. J. Does obesity affect patient-reported outcomes following total knee arthroplasty? BMC Musculoskelet. Disord. 23, 55 (2022).

pubmed: 35039019 pmcid: 8764810 doi: 10.1186/s12891-022-04997-4

Oo, W. M., Mobasheri, A. & Hunter, D. J. A narrative review of anti-obesity medications for obese patients with osteoarthritis. Expert. Opin. Pharmacother. 23, 1381–1395 (2022).

pubmed: 35855642 doi: 10.1080/14656566.2022.2104636

Lim, Y. Z. et al. Metformin as a potential disease-modifying drug in osteoarthritis: a systematic review of pre-clinical and human studies. Osteoarthr. Cartil. 30, 1434–1442 (2022).

doi: 10.1016/j.joca.2022.05.005

Li, H. et al. Exploration of metformin as novel therapy for osteoarthritis: preventing cartilage degeneration and reducing pain behavior. Arthritis Res. Ther. 22, 34 (2020).

pubmed: 32087740 pmcid: 7036179 doi: 10.1186/s13075-020-2129-y

Li, J. et al. Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann. Rheum. Dis. 79, 635–645 (2020).

pubmed: 32156705 doi: 10.1136/annrheumdis-2019-216713

Na, H. S. et al. Metformin attenuates monosodium-iodoacetate-induced osteoarthritis via regulation of pain mediators and the autophagy–lysosomal pathway. Cells 10, 681 (2021).

pubmed: 33808727 pmcid: 8003384 doi: 10.3390/cells10030681

Nielen, J. T. H. et al. Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case–control study. Br. J. Clin. Pharmacol. 81, 370–378 (2016).

pubmed: 26374732 doi: 10.1111/bcp.12786

Sayiner, Z. DPP-4 inhibitors increase the incidence of arthritis/arthralgia but do not affect autoimmunity. Acta Endocrinol. Buchar. 14, 473–476 (2018).

pubmed: 31149299 pmcid: 6516418

Riddle, D. L., Moxley, G. & Dumenci, L. Associations between tatin use and changes in pain, function and structural progression: a longitudinal study of persons with knee osteoarthritis. Ann. Rheum. Dis. 72, 196–203 (2013).

pubmed: 23172752 doi: 10.1136/annrheumdis-2012-202159

Veronese, N. et al. Statin use and knee osteoarthritis outcomes: a longitudinal cohort study. Arthritis Care Res. 71, 1052–1058 (2019).

doi: 10.1002/acr.23735

Zhang, Z. et al. The association between statin use and osteoarthritis-related outcomes: an updated systematic review and meta-analysis. Front. Pharmacol. 13, 1003370 (2022).

pubmed: 36506528 pmcid: 9729269 doi: 10.3389/fphar.2022.1003370

Nogueira-Recalde, U. et al. Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy. EBioMedicine 45, 588–605 (2019).

pubmed: 31285188 pmcid: 6642320 doi: 10.1016/j.ebiom.2019.06.049

Alimoradi, N., Tahami, M., Firouzabadi, N., Haem, E. & Ramezani, A. Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA. Arthritis Res. Ther. 25, 35 (2023).

pubmed: 36879307 pmcid: 9990216 doi: 10.1186/s13075-023-03025-7

Angeli, F., Trapasso, M., Signorotti, S., Verdecchia, P. & Reboldi, G. Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain. Expert. Rev. Clin. Pharmacol. 11, 1073–1084 (2018).

pubmed: 30362840 doi: 10.1080/17512433.2018.1540299

Shirinsky, I. & Shirinsky, V. Does renin-angiotensin-aldosterone system blockade influence pain, function and radiographic progression in knee osteoarthritis? An analysis of osteoarthritis initiative data. Ann. Rheum. Dis. 75, 835 abstr. SAT0453 (2016).

doi: 10.1136/annrheumdis-2016-eular.2888

Daniilidis, K., Georges, P., Tibesku, C. O. & Prehm, P. Positive side effects of Ca antagonists for osteoarthritic joints – results of an in vivo pilot study. J. Orthop. Surg. 10, 1 (2015).

doi: 10.1186/s13018-014-0138-8

de Sá, G. A. et al. Angiotensin II triggers knee joint lesions in experimental osteoarthritis. Bone 145, 115842 (2021).

pubmed: 33422700 doi: 10.1016/j.bone.2021.115842

Wei, J. et al. Thiazide diuretics and risk of knee replacement surgery among patients with knee osteoarthritis: a general population-based cohort study. Osteoarthr. Cartil. 27, 1454–1461 (2019).

doi: 10.1016/j.joca.2019.05.020

Nakafero, G. et al. β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score-matched cohort study. Rheumatology 60, 5686–5696 (2021).

pubmed: 33710319 pmcid: 8645269 doi: 10.1093/rheumatology/keab234

Valdes, A. M. et al. Association of beta-blocker use with less prevalent joint pain and lower opioid requirement in people with osteoarthritis. Arthritis Care Res. 69, 1076–1081 (2017).

doi: 10.1002/acr.23091

Li, M. et al. The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis – a comparative study with data from Osteoarthritis Initiative. J. Clin. Hypertens. 23, 2009–2015 (2021).

doi: 10.1111/jch.14362

Strebkova, E. & Alekseeva, L. Evaluation of the use of orlistat in the complex treatment of obesity in patients with knee osteoarthritis. Ann. Rheum. Dis. 78, 518 abstr. THU0456 (2019).

Meurot, C. et al. Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis. Sci. Rep. 12, 1567 (2022).

pubmed: 35091584 pmcid: 8799666 doi: 10.1038/s41598-022-05323-7

Zhu, H. et al. Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort. Ann. Rheum. Dis. 82, 1218–1226 (2023).

pubmed: 37258065

Drucker, D. J. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 27, 740–756 (2018).

pubmed: 29617641 doi: 10.1016/j.cmet.2018.03.001

Liu, F. et al. The effects of glucagon-like peptide-1 receptor agonists on adipose tissues in patients with type 2 diabetes: a meta-analysis of randomised controlled trials. PLoS ONE 17, e0270899 (2022).

pubmed: 35797355 pmcid: 9262225 doi: 10.1371/journal.pone.0270899

Iepsen, E. W. et al. Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. Int. J. Obes. 39, 834–841 (2015).

doi: 10.1038/ijo.2014.177

Lee, Y.-S. & Jun, H.-S. Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediators Inflamm. 2016, 3094642 (2016).

pubmed: 27110066 pmcid: 4823510 doi: 10.1155/2016/3094642

Iwasaki, Y. et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nat. Commun. 9, 113 (2018).

pubmed: 29317623 pmcid: 5760716 doi: 10.1038/s41467-017-02488-y

Jolivalt, C. G., Fineman, M., Deacon, C. F., Carr, R. D. & Calcutt, N. A. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice. Diabetes Obes. Metab. 13, 990–1000 (2011).

pubmed: 21635674 pmcid: 3177968 doi: 10.1111/j.1463-1326.2011.01431.x

Kitano, M. et al. Effects of low-intensity pulsed ultrasound on the infrapatellar fat pad in knee osteoarthritis: a randomized, double blind, placebo-controlled trial. J. Phys. Ther. Sci. 35, 163–169 (2023).

pubmed: 36866007 pmcid: 9974316 doi: 10.1589/jpts.35.163

Pinsornsak, P., Naratrikun, K. & Chumchuen, S. The effect of infrapatellar fat pad excision on complications after minimally invasive TKA: a randomized controlled trial. Clin. Orthop. Relat. Res. 472, 695–701 (2014).

pubmed: 24136801 doi: 10.1007/s11999-013-3321-z

Wang, Y. et al. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative – a prospective cohort study. Arthritis Res. Ther. 21, 127 (2019).

pubmed: 31126352 pmcid: 6534888 doi: 10.1186/s13075-019-1915-x

Lai, F. T. T. et al. Metformin use and the risk of total knee replacement among diabetic patients: a propensity-score-matched retrospective cohort study. Sci. Rep. 12, 11571 (2022).

pubmed: 35798867 pmcid: 9262887 doi: 10.1038/s41598-022-15871-7

Zhu, Z. et al. Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort study. Can. Med. Assoc. J. 194, E1672–E1684 (2022).

doi: 10.1503/cmaj.220952

Mohammed, M. M., Al-Shamma, K. J. & Jassim, N. A. Evaluation of the clinical use of metformin or pioglitazone in combination with meloxicam in patients with knee osteoarthritis; using Knee Injury and Osteoarthritis outcome Score. Iraqi J. Pharm. Sci. 23, 13–23 (2017).

Lu, C.-H. et al. Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: a nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE 13, e0191242 (2018).

pubmed: 29385156 pmcid: 5791980 doi: 10.1371/journal.pone.0191242

Ashwell, M. & Gibson, S. A proposal for a primary screening tool: ‘Keep your waist circumference to less than half your height’. BMC Med. 12, 207 (2014).

pubmed: 25377944 pmcid: 4223160 doi: 10.1186/s12916-014-0207-1

Ashwell, M., Gunn, P. & Gibson, S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis: waist-to-height ratio as a screening tool. Obes. Rev. 13, 275–286 (2012).

pubmed: 22106927 doi: 10.1111/j.1467-789X.2011.00952.x

NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Obesity in Adults (US). Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Report No. 98-4083 (National Heart, Lung, and Blood Institute, 1998).

Price, G. M., Uauy, R., Breeze, E., Bulpitt, C. J. & Fletcher, A. E. Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am. J. Clin. Nutr. 84, 449–460 (2006).

pubmed: 16895897 doi: 10.1093/ajcn/84.2.449

The role of obesity and adipose tissue dysfunction in osteoarthritis pain.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Marie Binvignat (M)

Jérémie Sellam (J)

Francis Berenbaum (F)

David T Felson (DT)

Classifications MeSH